Clinical Trial Update: A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 trial evaluating GPC3-targeted CAR-T cells delivered by intratumor injection for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• GPC3-CART (GPC3-targeted CAR-T cells)

Snippet

Sponsor: Shanghai GeneChem Co., Ltd. | Conditions: Carcinoma, Hepatocellular | Phase 1, Phase 2 | Status: UNKNOWN